Literature DB >> 10342372

A comparison of the early inflammatory effects of an agr-/sar- versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis.

M J Giese1, J A Berliner, A Riesner, E A Wagar, B J Mondino.   

Abstract

PURPOSE: We examined the ability of a wild type and an isogenic mutant strain of Staphylococcus aureus, deficient in the production of hemolysins and lipase (agr (-)/sar (-)), to induce endophthalmitis and inflammatory cell infiltration into the eye at 6, 24 and 48 hours after injection in a rat model of endophthalmitis.
METHODS: Rat eyes were injected with 25 microl of viable S. aureus or sterile saline. Eyes were graded for clinical signs of inflammation daily, removed and processed for standard histologic analysis 6, 24 and 48 hours after injections. Comparisons of clinical scores and mean inflammatory cell numbers were made between S. aureus and control injected eyes.
RESULTS: Both experimental groups developed clinical signs of endophthalmitis and demonstrated infiltration of inflammatory cells at 24 and 48 hours. Clinical inflammation in the Mutant I group was less than the wild type group at these times and significantly less at 48 hours (p<0.05). No statistically significant difference in the number of inflammatory cells was detected between the wild type and Mutant I injected eyes at 24 hours. At 48 hours, inflammatory cells increased by 75.0% in the wild type group and decreased by 19.0% in the Mutant I group and a statistically significant difference was seen between these two groups (p<0.05). At all times, the majority of inflammatory cells were neutrophils. By 48 hours, an increase in monocytes-macrophages was noted.
CONCLUSION: Both strains of S. aureus induced clinical signs of inflammation and inflammatory cell infiltration. Clinical inflammation and inflammatory cell numbers were less in rats injected with the Mutant I strain. These results suggest that hemolysins and lipase may be important in the early induction phase of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10342372     DOI: 10.1076/ceyr.18.3.177.5370

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  12 in total

1.  Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo.

Authors:  Jeremy M Yarwood; John K McCormick; Michael L Paustian; Vivek Kapur; Patrick M Schlievert
Journal:  J Bacteriol       Date:  2002-02       Impact factor: 3.490

Review 2.  Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions.

Authors:  Michelle C Callegan; Michael Engelbert; David W Parke; Bradley D Jett; Michael S Gilmore
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

3.  Moxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.

Authors:  Stéphane Bronner; François Jehl; Jean-Daniel Peter; Marie-Cécile Ploy; Corinne Renault; Pierre Arvis; Henri Monteil; Gilles Prevost
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

Review 4.  Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection.

Authors:  Ama Sadaka; Marlene L Durand; Michael S Gilmore
Journal:  Prog Retin Eye Res       Date:  2012-04-11       Impact factor: 21.198

Review 5.  Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions.

Authors:  Michelle C Callegan; Michael S Gilmore; Meredith Gregory; Raniyah T Ramadan; Brandt J Wiskur; Andrea L Moyer; Jonathan J Hunt; Billy D Novosad
Journal:  Prog Retin Eye Res       Date:  2007-01-22       Impact factor: 21.198

6.  Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors:  Dennis P Han
Journal:  Trans Am Ophthalmol Soc       Date:  2004

7.  Relationship of plcR-regulated factors to Bacillus endophthalmitis virulence.

Authors:  Michelle C Callegan; Scott T Kane; D Clay Cochran; Michael S Gilmore; Myriam Gominet; Didier Lereclus
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance.

Authors:  Norito Sugi; Emily A Whiston; Bruce R Ksander; Meredith S Gregory
Journal:  Infect Immun       Date:  2013-04-08       Impact factor: 3.441

9.  Bacterial and fungal keratitis in Upper Egypt: in vitro screening of enzymes, toxins and antifungal activity.

Authors:  Abdullah A Gharamah; Ahmed M Moharram; Mady A Ismail; Ashraf K Al-Hussaini
Journal:  Indian J Ophthalmol       Date:  2014-02       Impact factor: 1.848

Review 10.  The Pathogenesis of Staphylococcus aureus Eye Infections.

Authors:  Richard J O'Callaghan
Journal:  Pathogens       Date:  2018-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.